Oxymorphone Extended-Release Tablets and Trastuzumab and Hyaluronidase
Determining the interaction of Oxymorphone Extended-Release Tablets and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: oxymorphone
Brand name: Opana, Opana ER, Numorphan HCl
Synonyms: Oxymorphone
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Oxymorphone Extended-Release Tablets-Trastuzumab Injection (Intravenous)
- Oxymorphone Extended-Release Tablets-Trastuzumab Intravenous
- Oxymorphone Extended-Release Tablets-Trastuzumab-anns
- Oxymorphone Extended-Release Tablets-Trastuzumab-dkst
- Oxymorphone Extended-Release Tablets-Trastuzumab-dkst Intravenous
- Oxymorphone Extended-Release Tablets-Trasylol
- Trastuzumab and Hyaluronidase-Oxymorphone Hydrochloride
- Trastuzumab and Hyaluronidase-Oxymorphone Injection
- Trastuzumab and Hyaluronidase-Oxymorphone Tablets
- Trastuzumab and Hyaluronidase-Oxytocin
- Trastuzumab and Hyaluronidase-Oxytocin Intravenous, Intramuscular
- Trastuzumab and Hyaluronidase-Oxytrol